Edwards EVOQUE Eos MISCEND Study
Edwards EVOQUE Eos MISCEND Study
Active, not recruiting · NCT02718001 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Edwards EVOQUE Eos MISCEND Study | Deglutition Disorders, Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, digestive system disorder, dyskinesia of esophagus, esophageal disorder, follicular lymphoma, gastroesophageal reflux disease, heart disorder, heart valve disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mitral valve insufficiency, neoplasm | Active, not recruiting | Not applicable | 2026-04-13 | NCT02718001 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Edwards Lifesciences | 59 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.